BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,312 | +13.6% | 40 | 0.0% | 0.00% | – |
Q1 2024 | $3,795 | -33.6% | 40 | -35.5% | 0.00% | – |
Q4 2023 | $5,719 | +3687.4% | 62 | +1966.7% | 0.00% | – |
Q3 2023 | $151 | -98.3% | 3 | -97.9% | 0.00% | -100.0% |
Q2 2023 | $8,975 | +6548.1% | 142 | +4633.3% | 0.00% | – |
Q1 2023 | $135 | -89.7% | 3 | -90.0% | 0.00% | – |
Q4 2022 | $1,314 | +31.4% | 30 | +42.9% | 0.00% | – |
Q3 2022 | $1,000 | -66.7% | 21 | -69.6% | 0.00% | – |
Q2 2022 | $3,000 | +200.0% | 69 | +666.7% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 9 | -35.7% | 0.00% | – |
Q4 2021 | $1,000 | -75.0% | 14 | -65.0% | 0.00% | -100.0% |
Q3 2021 | $4,000 | +300.0% | 40 | +344.4% | 0.00% | – |
Q2 2021 | $1,000 | -50.0% | 9 | -64.0% | 0.00% | – |
Q1 2021 | $2,000 | – | 25 | +525.0% | 0.00% | – |
Q4 2020 | $0 | – | 4 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 4 | 0.0% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 4 | -99.6% | 0.00% | -100.0% |
Q1 2020 | $56,000 | +600.0% | 969 | +822.9% | 0.01% | +800.0% |
Q4 2019 | $8,000 | -69.2% | 105 | -70.8% | 0.00% | -75.0% |
Q3 2019 | $26,000 | -21.2% | 359 | 0.0% | 0.00% | -20.0% |
Q2 2019 | $33,000 | – | 359 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |